the in vitro activity of enoxacin ( ci 919 , at 2266 ) , a new oral quinolone carboxylic acid compound , was compared with those of gentamicin , tobramycin , amikacin , azlocillin , piperacillin , aztreonam , moxalactam , imipenem , cefsulodin , ceftazidime , and cefoperazone against 101 aminoglycoside-susceptible and 105 aminoglycoside-resistant pseudomonas aeruginosa strains .
C0002499
amikacin
C0002556
aminoglycoside